Covered recipient · General Payments record
TANYA VYSOTSKY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$5,931.24
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,436.45 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $421.04 | 4 |
| UCB, Inc. | $170.90 | 2 |
| Arcutis Biotherapeutics, Inc. | $130.08 | 1 |
| Paratek Pharmaceuticals, Inc. | $124.97 | 1 |
| Amgen Inc. | $122.43 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $114.61 | 1 |
| Galderma Laboratories, L.P. | $114.32 | 1 |
| Dermavant Sciences, Inc. | $88.82 | 1 |
| Janssen Scientific Affairs, LLC | $86.58 | 1 |
| E.R. Squibb & Sons, L.L.C. | $62.70 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.23 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366756 | CMS |
| ABBVIE INC. | $149.41 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366758 | CMS |
| ABBVIE INC. | $71.58 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366760 | CMS |
| ABBVIE INC. | $74.82 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366762 | CMS |
| Amgen Inc. | $122.43 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711466 | CMS |
| Arcutis Biotherapeutics, Inc. | $130.08 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121124377 | CMS |
| Dermavant Sciences, Inc. | $88.82 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128022190 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101606790 | CMS |
| E.R. Squibb & Sons, L.L.C. | $45.42 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101606794 | CMS |
| Galderma Laboratories, L.P. | $114.32 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145398928 | CMS |
| Janssen Scientific Affairs, LLC | $86.58 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078851712 | CMS |
| Novartis Pharmaceuticals Corporation | $114.61 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087361018 | CMS |
| Paratek Pharmaceuticals, Inc. | $124.97 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113935272 | CMS |
| UCB, Inc. | $120.90 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029724 | CMS |
| UCB, Inc. | $50.00 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029726 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.